Nucleic Acid Isolation And Purification Market

Nucleic Acid Isolation and Purification Market Size & Growth (2022 to 2027)

The size of the global nucleic acid isolation and purification market was valued at USD 3.52 billion in 2022 and is expected to grow at a CAGR of 8.27%, to reach USD 5.24 billion by 2027. Nucleic acid and Isolation is a procedure of purifying DNA from the collected sample using both the physical and chemical processes.

DRIVERS

The cost associated with genetic sequencing reduces; the advanced technologies in the development of genetics, intake of personalized medicine as well as diagnostics are some of the factors that propel the market growth. Also, factors like the development of new drugs, mergers and acquisitions, and partnerships are also the factors that boost up the market. The increase in implementation of nucleic acid and for molecular diagnostics and growth in the markets is due to the automation of products.

Growing the safety of the workers, the ability to be reproduced, timeliness, and accurate results are important in the prospect of laboratory efficiency, have accelerated the market growth. The increasing demand for the manufacturing industry helps in the development of nucleic acid-based products like DNA vaccines, double-stranded RNA non-coding molecules which have surged the market growth of Nucleic Acid Isolation and Purification.

RESTRAINTS

Low penetration of the introduction of equipment’s for the procedure of nucleic acid and isolation purification in the existing countries and also the increase in the number of processes that make the markets stronger are some of the factors that hamper the market growth.

The costs that are associated with the instruments are very high where the people can’t afford the treatment, and also increase in funds from the government for the research and development activities are the major factors that hinder the market growth.

COVID 19 IMPACT ON NUCLEIC ACID ISOLATION AND PURIFICATION MARKET

The COVID 19 is an inimitable global public health emergency that has affected every sector, including healthcare. The COVID 19 pandemic confirms how the research efforts to develop drug treatments or vaccines quickened up during emergency need. The need for supplies and support for scientists working to truncate the spread of the COVID 19 virus is emergency and immediate—the COVID 19 works as a positive cause for nucleic acid isolation and purification market growth. Scientists and pharma companies worldwide spotlight developing specific assays and kits for quickly detecting the virus (SARS-CoV-2). The pharmaceutical and biotechnology companies are introducing new diagnostic solutions for recognizing developing infections and diseases. For instance, in February 2021, Applied Biosystems TaqPath COVID 19 HT Kit launched by Thermo Fisher Scientific, Inc. to carry out COVID 19 diagnostic assays. The escalating collaborations among various companies and organizations in the biotech industry in one factor accumulating the nucleic acid and isolation purification market growth. For instance, in March 2020, Zymo Research and Tecan were accompanied to launch ready-to-use processing products that can update DNA or RNA from COVID 19 specimens. Promega Corporation helps researchers understand the molecular mechanisms by which the existing or developing viruses infect humans to advance proper identifying procedures.

REPORT COVERAGE

This research report on the Global Nucleic Acid Isolation and Purification Market has been segmented and sub-segmented into the following categories and calculated market size and forecast for each segment until 2026.

Nucleic Acid Isolation and Purification Market Analysis – By Product

• Reagents
• Kits
• Instruments

Based on the product analysis, the Kits segment is accounted for the largest share in the nucleic acid isolation and purification market globally, and the segment product is caused by less cost, simple use of these kits in applications like gene sequencing, gene cloning, and molecular diagnostics. These kits are used to segregate DNA or RNA from bacteria, plasmids, viruses,es and many more.

The instruments segment is considered to be the quickest growing and developing product towards the nucleic acid isolation and purification market due to the ongoing upgrading of advance technologically and reliable robotic systems based on various technologies like magnetic beads, spin columns.

Nucleic Acid Isolation and Purification Market Analysis – By Technology

• Column-based
• Reagent-based
• Magnetic bead-based
• Others

Based on the technology analysis, the column-based segment accounts for the largest share in the nucleic acid isolation and purification market as this column-based is so cost-effective, simple, easy and quick. This is most commonly used in diagnostic laboratories as it required no dangerous chemicals.

Nucleic Acid Isolation and Purification Market Analysis – By Application

• Genomic DNA isolation and purification
• Micro RNA isolation and purification
• Blood RNA isolation and purification
• mRNA isolation and purification
• Plasmid DNA isolation and purification
• Total RNA isolation and purification
• PCR clean up

Based on the application analysis, the DNA isolation and purification segment account for the largest share in the global nucleic acid isolation and purification market over the analysis period as the continuous discovery of easy, rapid, and inexpensive methods bolster the market growth.

Nucleic Acid Isolation and Purification Market Analysis – By End-User

• Pharmaceutical and biotechnology companies
• Academic and government research institutes
• Contract research organizations
• Hospitals
• Diagnostic Centers

Based on the end-user analysis, the hospitals and diagnostic centers segment are expected to lead the nucleic acid isolation and purification market in terms of revenue due to an increase in the utilization of nucleic acid-based therapeutics for early and correct diagnosis of genetic and inherited diseases. The rising number of genetic fingerprinting, prenatal testing, and liquid biopsies propel the growth of this segment.

Regional Analysis

North America Nucleic Acid Isolation and Purification Market is dominating in the global 2020. The market is held to be the largest share during the overcast period due to expenditure in research and development in biotechnology & pharmaceutical companies, advanced technologies, and government support. The U.S is leading the region with the largest share followed by Canada.

Europe Nucleic Acid Isolation and Purification Market is expected to have robust growth during the period due to economic strength to obtain expensive tools, and favorable reimbursement policies.

Asia-Pacific Nucleic Acid Isolation and Purification Market is expected to grow with the highest CAGR with promising opportunities in the nucleic acid isolation and purification market over the review period. The growth in this region is attributed due to different emerging economies, increasing awareness regarding the usage of nucleic acid in different sectors. China is projected to hold the largest share in the market due to rapid growth in DNA or RNA libraries for NGS.

Latin America Nucleic Acid Isolation and Purification Market is considered to grow with steady and continuous growth with a share of 12% in the nucleic acid isolation and purification market due to growing wide range of applications of nucleic acid tests, advanced technologies, and growing R&D funds and investments from the government which surges up the market growth. Brazil is the largest country of this region followed by Mexico and Argentina which are exciting their investments in the market.

Middle East & Africa Nucleic Acid Isolation and Purification Market is considered to grow very slowly in the nucleic acid isolation and purification market during the forecast period as the private organizations play a major role in capitalizing the healthcare domain in Africa more than 50% of the investments being undertaken.

Key Market Players Operating the Global Nucleic Acid Isolation and Purification Market Profiled in the Report are Qiagen, Bio-Rad Laboratories Inc, Illumina Inc, Agilent Technologies Inc, Thermo Fischer Scientific Inc, F. Hoffmann-La Roche AG, Sigma-Aldrich Co. LLC, General Electric Company, Danaher Corporation, Promega Corporation, Life Technologies, Roche Applied Sciences, Takara Bio, Inc.

Recent Market Developments

• On April 27, 2020, Qiagen and Gilson have made a strategic partnership that offers the researchers the capability to restrict the operator-dependent variation in manual nucleic acid extraction which results in advancing the trackability of the workflows. This collaboration of the two companies creates consistency and increases their confidence in extracting their protocols.
• On April 24, 2020, Thermo Fisher Scientific and Hamilton both together have introduced forensic laboratory and the forensic scientists have accessibility for their new business which is easy to use automated DNA sample which is designed to extract nucleic acids.
• On July 16, 2020, Promega Corporation Maxwell RSC 48 instrument and RSC Viral Total Nucleic acid purification kit are now sanctioned RNA extraction options in CDC diagnostic protocol for emergency use.